169 related articles for article (PubMed ID: 9155047)
1. All-trans retinoic acid decreases susceptibility of a gastric cancer cell line to lymphokine-activated killer cytotoxicity.
Chao TY; Jiang SY; Shyu RY; Yeh MY; Chu TM
Br J Cancer; 1997; 75(9):1284-90. PubMed ID: 9155047
[TBL] [Abstract][Full Text] [Related]
2. Interferon gamma enhances lymphokine-activated killer cell adhesion but not lysis of head and neck squamous cell carcinoma.
Scher RL; Carras A; Schwab D; Richtsmeier WJ; Koch WM
Arch Otolaryngol Head Neck Surg; 1995 Nov; 121(11):1271-5. PubMed ID: 7576474
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of murine lymphokine-activated killer cell activity by retinoic acid.
Lin TH; Chu TM
Cancer Res; 1990 May; 50(10):3013-8. PubMed ID: 1970751
[TBL] [Abstract][Full Text] [Related]
4. Cancer cell cycle and adoptive immunotherapy using lymphokine-activated killer cells.
Ejiri Y; Ohara M; Suzuki T; Kasukawa R
Fukushima J Med Sci; 1997 Dec; 43(2):61-73. PubMed ID: 9640842
[TBL] [Abstract][Full Text] [Related]
5. Growth regulation by all-trans-retinoic acid and retinoic acid receptor messenger ribonucleic acids expression in gastric cancer cells.
Shyu RY; Jiang SY; Huang SL; Chang TC; Wu KL; Roffler SR; Yeh MY
Eur J Cancer; 1995; 31A(2):237-43. PubMed ID: 7718331
[TBL] [Abstract][Full Text] [Related]
6. Modulation of leukemic cell sensitivity to lymphokine-activated killer cytolysis: role of intercellular adhesion molecule-1.
Triozzi PL; Eicher DM; Smoot J; Rinehart JJ
Exp Hematol; 1992 Oct; 20(9):1072-6. PubMed ID: 1361453
[TBL] [Abstract][Full Text] [Related]
7. Retinoic acid causes cell growth arrest and an increase in p27 in F9 wild type but not in F9 retinoic acid receptor beta2 knockout cells.
Li R; Faria TN; Boehm M; Nabel EG; Gudas LJ
Exp Cell Res; 2004 Mar; 294(1):290-300. PubMed ID: 14980522
[TBL] [Abstract][Full Text] [Related]
8. Bcl-2 accelerates retinoic acid-induced growth arrest and recovery in human gastric cancer cells.
Chou HK; Chen SL; Hsu CT; Chao YC; Tsao YP
Biochem J; 2000 Jun; 348 Pt 2(Pt 2):473-9. PubMed ID: 10816444
[TBL] [Abstract][Full Text] [Related]
9. Influence of malignant cell clonogenic capacities and position along the maturation pathway on their susceptibility to lymphokine-activated killer cell cytotoxicity.
Thomas X; Anglaret B; Adeleine P; Maritaz O; Bailly M; Fiere D; Archimbaud E
Leuk Lymphoma; 1998 Jan; 28(3-4):343-53. PubMed ID: 9517505
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of protein kinase C in murine lymphokine-activated killer cells by retinoic acid.
Lin TH; Chu TM
J Biol Chem; 1992 Jan; 267(2):1335-9. PubMed ID: 1730652
[TBL] [Abstract][Full Text] [Related]
11. Growth inhibition of cultured human gastric cancer cells by 9-cis-retinoic acid with induction of cdk inhibitor Waf1/Cip1/Sdi1/p21 protein.
Naka K; Yokozaki H; Domen T; Hayashi K; Kuniyasu H; Yasui W; Lotan R; Tahara E
Differentiation; 1997 Aug; 61(5):313-20. PubMed ID: 9342842
[TBL] [Abstract][Full Text] [Related]
12. The role of human melanoma cell ICAM-1 expression on lymphokine activated killer cell-mediated lysis, and the effect of retinoic acid.
Alexander CL; Edward M; MacKie RM
Br J Cancer; 1999 Jul; 80(10):1494-500. PubMed ID: 10408388
[TBL] [Abstract][Full Text] [Related]
13. Retinoic acid modulation of alpha(1-->2) fucosyltransferase activity and sensitivity of tumor cells to LAK-mediated cytotoxicity.
Labarrière N; Piau JP; Zennadi R; Blanchardie P; Denis M; Lustenberger P
In Vitro Cell Dev Biol; 1993 Feb; 29A(2):140-4. PubMed ID: 8473271
[TBL] [Abstract][Full Text] [Related]
14. 5-Fluorouracil increases susceptibility of renal cell cancer cell lines to lymphokine-activated killer cells: evidence for alteration not at the level of recognition but at a post-binding stage of the lytic cycle.
Tomita Y; Imai T; Katagiri A; Kimura M; Saitoh K; Sato S
Cancer Lett; 1993 Nov; 75(1):27-34. PubMed ID: 7904537
[TBL] [Abstract][Full Text] [Related]
15. Cis-diamminedichloroplatinum(II) augments expression of tumor-associated antigens on human gastric cancer cell line KATO-3 and increases susceptibility and binding of tumor cells to various cytotoxic effector cells.
Hayashi H; Nio Y; Kawabata K; Araya S; Imamura M
J Surg Oncol; 1996 Jul; 62(3):162-70. PubMed ID: 8667622
[TBL] [Abstract][Full Text] [Related]
16. Differentiation-related expression of adhesion molecules and receptors on human neuroblastoma tissues, cell lines and variants.
Gross N; Favre S; Beck D; Meyer M
Int J Cancer; 1992 Aug; 52(1):85-91. PubMed ID: 1354203
[TBL] [Abstract][Full Text] [Related]
17. Granulocytic differentiation of human NB4 promyelocytic leukemia cells induced by all-trans retinoic acid metabolites.
Idres N; Benoît G; Flexor MA; Lanotte M; Chabot GG
Cancer Res; 2001 Jan; 61(2):700-5. PubMed ID: 11212271
[TBL] [Abstract][Full Text] [Related]
18. Increased susceptibility of IFN-gamma-treated neuroblastoma cells to lysis by lymphokine-activated killer cells: participation of ICAM-1 induction on target cells.
Naganuma H; Kiessling R; Patarroyo M; Hansson M; Handgretinger R; Grönberg A
Int J Cancer; 1991 Feb; 47(4):527-32. PubMed ID: 1671670
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of lymphokine-activated killer cell cytotoxicity implicated in the increased expression of surface adhesion molecules on tumor cells treated with anticancer agents.
Ishihata R; Ejiri Y; Okubo M; Ohara M; Kasukawa R
Cancer Invest; 1996; 14(5):427-34. PubMed ID: 8816858
[TBL] [Abstract][Full Text] [Related]
20. Cytokine regulation of cell-to-cell interactions in lymphokine-activated killer cell cytotoxicity in vitro.
Takahashi T; Ishikura H; Iwai K; Takahashi C; Kato H; Tanabe T; Yoshiki T
Cancer Immunol Immunother; 1993; 36(2):76-82. PubMed ID: 8093857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]